Hillsdale Investment Management’s Globus Medical GMED Stock Holding History

Hillsdale Investment Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.75M	Buy	43,500 +2,000	+5%	+$180K	0.1%	246
2025 Q4	$3.62M	Buy	+41,500	New	+$3.15M	0.1%	275
2023 Q3	–	Sell	-180	Closed	-$10.7K	–	600
2023 Q2	$10.7K	Sell	180 -7,100	-98%	-$405K	﹤0.01%	435
2023 Q1	$412K	Buy	+7,280	New	+$467K	0.04%	369
2020 Q2	–	Sell	-81,100	Closed	-$3.45M	–	617
2020 Q1	$3.45M	Sell	81,100 -400	-0.5%	-$19.8K	0.42%	56
2019 Q4	$4.8M	Buy	+81,500	New	+$4.42M	0.42%	64
2019 Q3	–	Sell	-35,000	Closed	-$1.48M	–	641
2019 Q2	$1.48M	Hold	35,000	–	–	0.15%	151
2019 Q1	$1.73M	Hold	35,000	–	–	0.16%	135
2018 Q4	$1.51M	Buy	35,000 +7,000	+25%	+$349K	0.18%	134
2018 Q3	$1.59M	Buy	28,000 +2,000	+8%	+$105K	0.21%	97
2018 Q2	$1.31M	Buy	+26,000	New	+$1.36M	0.16%	143

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hillsdale Investment Management's GMED Position: Q1 2026 in Review

Hillsdale Investment Management increased its Globus Medical (GMED) stake by 4.8% in Q1 2026, buying an estimated $180K and bringing the position to 43,500 shares worth $3.75M. The position accounts for 0.1% of the portfolio, ranked #246.

Hillsdale Investment Management first reported a position in GMED in Q2 2018 and has held it in 11 quarters since. The position peaked at $4.8M in Q4 2019. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Hillsdale Investment Management held 43,500 shares of Globus Medical worth $3.75M as of Q1 2026.
Hillsdale Investment Management bought 2,000 Globus Medical shares in Q1 2026, an estimated $180K.
Globus Medical made up 0.1% of Hillsdale Investment Management's portfolio in Q1 2026, its #246 holding.
Hillsdale Investment Management first reported a position in Globus Medical in Q2 2018 and has held it in 11 quarters since.
Hillsdale Investment Management's Globus Medical position peaked at $4.8M in Q4 2019.
603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.